prof.eric.claassen@gmail.com Eric Claassen, Immunologist Professor Erasmus Medical Center

Similar documents
Probiotics for the Treatment of Adult Gastrointestinal Disorders

Symptomspesifikke probiotikum. Linda Mulder, MSc. Vårseminaret 2014

Probiotics for Gut Health

Current and Future Applications of Probiotic Science

PROBIOTICS. what they are and what they can do for you. A patient s guide from your doctor and

Observational studies on homeopathy

EVIDENCE BASED TREATMENT OF CROHN S DISEASE. Dr E Ndabaneze

Probiotics are live microorganisms

PROBIOTICS. Prof Kerryn Phelps 2012

C. difficile Infections

What Is Clostridium Difficile (C. Diff)? CLOSTRIDIUM DIFFICILE (C. DIFF)

Frequently Asked Questions: Ai-Detox

Inhibit terminal acid secretion from parietal cells by blocking H + /K + - ATPase pump

PHYSIOLOGY AND MAINTENANCE Vol. II Intestinal Microflora - Erkki Eerola, Wen Hua Ling

Develop an understanding of the differential diagnosis of pseudomembranous colitis

Peptic Ulcer. Anatomy The stomach is a hollow organ. It is located in the upper abdomen, under the ribs.

Prebiotics in Infant Nutrition

Migrene og mikroflora. Linda Mulder, MSc. Vårseminaret 2014

Clostridium difficile (C. difficile)

THE DIGESTIVE SYSTEM

Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria

What is Helicobacter pylori? hat problems can H. pylori cause? Does H. pylori cause cancer? ight H. pylori even be good for us?

Treatment and Prevention Options for Clostridium difficile Infection (CDI)

Learning Objectives. Introduction to Medical Careers. Vocabulary: Chapter 16 FACTS. Functions. Organs. Digestive System Chapter 16

ESCMID Online Lecture Library. by author

A link between gut microbiota, mucosal immunity and autoimmune arthritis. Hsin-Jung Joyce Wu "Microbiota and man: the story about us

Probiotics (printer-friendly)

What are peptic ulcers?

Antimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection

A Phase 2 Study of Interferon Beta-1a (Avonex ) in Ulcerative Colitis

Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis

Chronic Diarrhea in Children

Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis

Crohn's and Colitis UK Information Sheet. Students with IBD: a guide for universities and colleges

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis

Full version is >>> HERE <<<

BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY

Controlling intestinal microflora with BioHealth, MicroHealth and LactoHealth. Below illustration shows clearly the effects of unbalanced microflora

Problems of the Digestive System

Canadian Microbiome Initiative

More details >>> HERE <<<

Probiotics in food Health and nutritional properties and guidelines for evaluation

Report of the Veal Calf Vaccination Study with Rispoval IntraNasal (Zoetis)

Bowel Preparation for Colon Resection. Eric Klein, M.D. SUNY Downstate Department of Surgery

IBS. TomSult Sult, MD Patrick Hanaway, MD. Post Webinar Sept 21, 2011

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Nutrition and Toxicants in Autoimmune Disease: Implications for Prevention and Treatment

QUESTIONS TO ASK MY DOCTOR

Colon Cancer. What Is Colon Cancer? What Are the Screening Methods?

Why is prematurity a concern?

BioGaia a healthcare company working with probiotics

Colon and Rectal Cancer

British Journal of Nutrition

International Aloe Science Council Certified Facility and Products

Treatments, Tapers, and Transplants: Guidelines and Options for Complicated C. diff Patients MIA A. TAORMINA, DO, FACOI

Intra-abdominal abdominal Infections

Understanding Colitis and Crohn s Disease

7 Reasons You Can t Eat the Foods You Love!

Key Facts about Influenza (Flu) & Flu Vaccine

The Digestive System

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome

Irritable Bowel Syndrome

The impact of antibiotics on the gut microbiota

Equine Equine Diarrhea Diarrhea Diarrhea in the Horse: Salmonella and Other Infections Introduction Clinical Signs

News on modifying diseases therapies. Michel CLANET CHU Toulouse France ECTRIMS

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Update and Review of Medication Assisted Treatments

Testimony of Sidney Wolfe M.D. Health Research Group of Public Citizen FDA Drug Safety and Risk Management Advisory Committee

Final report of the BgVV Working Group "Probiotic Microorganism Cultures in Food" October 1999

Definition: What is the Microbiome- A Big Picture

Gastrointestinal Bleeding

Irritable Bowel Syndrome

Principles of Disease and Epidemiology. Copyright 2010 Pearson Education, Inc.

Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine

Viral Hepatitis A, B, and C

Long Term Use of Antacid Medications Can Cause an Increased Risk for Osteoporosis and Much More

Laparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions

The human gastrointestinal tract is colonized. Probiotics: A Review. Probiotics. Nitesh Upadhyay, MD, and Varsha Moudgal, MD

If you have a cold or the flu, you can spread the sickness to someone else. How does the sickness spread? Write your ideas on the lines below.

Paratyphoid prevention is better than cure Dr Ockert Botha (BVSc) Tel The causing bacteria

It s A Gut Feeling: Abdominal Pain in Children. David Deutsch, MD Pediatric Gastroenterology Rockford Health Physicians

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

CHAPTER 35 HUMAN IMMUNE SYSTEM STANDARDS:SC.912.L & SC.912.L.14.6

Week 6: Digestive Health

Transcription:

prof.eric.claassen@gmail.com Eric Claassen, Immunologist Professor Erasmus Medical Center Professor Business Management & Entrepreneurship in Health and Life Sciences (VU Amsterdam)

Darmvlokken (villi) geven oppervlakte vergroting De totale oppervlakte van de uitgespreide darm komt daarmee op meer dan 300 vierkante meter Dat is een tennisveld

400-900 species meeste zijn onbekend Wij hebben hen geaccepteerd als inwonende commensalen old friends Mouth 10 5 10 7 polymorph germs duodenum < 10 4-5 Streptococcus ileum 10 3 10 7 Streptococcus Bacteroides stomach 10 2 10 3 Streptococcus jenunum 10 5 10 6 Streptococcus colon 10 9 10 11 Bacteroides Clostridum Streptococcus Bifidobacteria Enterobacteria

Bacterieen moeten aanhechten aan darm eptiheel om te koloniseren: competitie

suikerkatabolieten vet- en aminozuurmetabolieten koolstofdioxide melkzuur azijnzuur mierenzuur (boterzuur indirect) ethanol diactyl acetaldehyde 3-hydroxy vetzuren phenyl-melkzuur caproïnezuur 4-hydroxy-phenyl melkzuur melkzuurbacteriën waterstofperoxide bacteriocinen bacteriocine-achtige molekulen aromaten heterocyclische molekulen Reuterine Reuteri-cycline kleine peptiden cyclische di-peptiden anti-fungale-peptiden zuurstofkatabolieten eiwitachtige stoffen

Darmwand en gezond epitheel is een barriere

Afbraak van de barriere functie -> opportunisten & ontsteking

Lactobacilli versterken tight junctions Occludin Claudin 1

% Bifidobacteria of total faecal bacteria (mean ± SE) Clinical Studies: Effects of the Prebiotic GOS/FOS Mixture in Infants 4-12 Weeks 80 70 - Bifidogenicity - 60 50 40 30 Knol et al., 2002 20 10 0 Human milk (n = 16) Control (n=18) study start after 4 weeks after 6 weeks

% Bifidobacteria of total faecal bacteria (mean ± SE) Clinical Studies: Effects of the Prebiotic GOS/FOS Mixture in Infants 4-12 Weeks 80 - Bifidogenicity - 70 60 * # 50 40 30 20 10 Human milk (n = 16) GOS/FOS (n=16) Control (n=18) * p<0.05, 6 wk vs. study start, # GOS/FOS vs. control Knol et al., 2002 0 study start after 4 weeks after 6 weeks

% w/w (vers) Witlof / Cichorei 15-20 Knoflook 9-16 Schorseneer 4-10 Prei 3-10 Ui 2-6 Artisjok 2-6 Asperge 2-3 Tarwemeel 1-4 Haver 0.5-1.5 Banaan 0.3-0.7

Hierarchy of evidence Science Clinical Trial paradox V A L I D I T Y Meta-analysis of RCTs Randomised controlled trial (RCT) Observational studies (case-control, cohort) Observational studies (case report, case series) Experimental studies B I A S

Line of no effect The forest plot LEFT LESS EFFECT RIGHT MORE EFFECT D Souza AL. et al. BMJ 2002; 324: 361-4

Eradication Helicobacter pylori Tong et al. Aliment Pharmacol Ther 2007;25:155 168

Eradication Helicobacter pylori Effective L acidophilus Bifidobacterium L casei Tong et al. Aliment Pharmacol Ther 2007;25:155 168

Duration of diarrhoea 9 RCTs, n=1714, WMD -23 h (-38 to -7) Szajewska et al. update 2010

AAD incidence (%) First Overpowered study 2012: 500+ AAD Volunteer study Ouwehand et al., in press 25 20 P=0.28 P=0.005 P=0.08 15 10 5 0 Placebo Low dose High dose Antibiotic-associated diarrhea (AAD) incidence by study group. Low dose 4.17 10 9 colony forming units (CFU), High-dose: 1.70 10 10 CFU, Placebo: microcrystalline cellulose.

A=strong, B=positive controlled trials but some negative studies, C= some positive but not enough for certainty

Recommendations for Probiotic Use or: A claims (Floch 2011) Infectious diarrhea children AAD (antibiotic associated diarrhea) Pouchitis Ulcerative Colitis (maintenance) Immune response Atopic Eczema

Major PMC s in preparation close to A-status Infection prevention IBD remission induction IBS; Irritable Bowel Syndrome NEC; Necrotising EnteroColitis CRC; Colorectal cancer Vaginosis & Vaginitis

Health Maintenance of Athletes with Supermarket Probiotics Mike Gleeson et al. School of Sport, Exercise & Health Sciences Loughborough University, UK

EFFECT OF A PROBIOTIC ON RESPIRATORY INFECTIONS AND SALIVA IGA DURING INTENSE MILITARY TRAINING 47 army cadets Daily 100 ml L. casei DN-114 001 probiotic drink or placebo for 3 weeks training, followed by a 5-day combat course No difference in incidence of respiratory illness Significant saliva IgA decrease only in placebo group Percentage change in saliva IgA 80 60 PRO PLA 40 20 0-20 -40 Before training After 3 weeks training After combat course After 1 week recovery Tiollier et al 2007 Military Med 172: 1006-1011 23

Healthy Shift-workers Probiotics and resistance to infections Gastro-intestinal and respiratory

Total Group Shift workers: On placebo : 26% reported sick (3days) Lactobacilli : 11% [p<0.01] (also 3days) on placebo : 33% reported sick Lactobacilli: none = 0% (p<0.005)

PI & Bleeding on Probing

CHALLENGES Metabolic syndrome (obesity) Malnutrition Athletes, Military, Shift-workers URTI & Respiratory Helicobacter pylori Gingivitis, Halithosis & Caries Depression, Anxiety, Stress -> anger

SAFETY results - Overall 300+ clinical studies analyzed 30.855 participants analyzed in studies Divided over treatment and control group Duration of studies Most common AE: Gastrointestinal disorders and infections No probiotic culture proven bacteraemia

Children: Good safety

Children: Good safety

Preliminary conclusion In controlled setting of clinical trials, probiotics and synbiotics are safe No significant difference between AEs in treatment and control groups Slightly protective effect Frequently documented clinical effect faster gastrointestinal transit, softer stools and reduced hospitalization duration Could reduce healthcare costs Probiotic efficacy remains controversial Approx. 20% does not show any efficacy 31

www.darmgezondheid.nl Parallelsessie Recidiverende infecties CDI prof.eric.claassen@gmail.com + 31 6 204 430 98

Clostridium difficile infectie (CDI)

.

.

Fecal Transplant Crackdown: FDA Moves To Regulate Infection-Fighting 'Stool' Treatment Summer 2013

AAD incidence (%) First Overpowered study 2012: 500+ AAD Volunteer study Ouwehand et al., in press 25 20 P=0.28 P=0.005 P=0.08 15 10 5 0 Placebo Low dose High dose Antibiotic-associated diarrhea (AAD) incidence by study group. Low dose 4.17 10 9 colony forming units (CFU), High-dose: 1.70 10 10 CFU, Placebo: microcrystalline cellulose.

Examples Atopic / Constitutional Eczema

The Africa Paradox and the hygiënehypothesis Yazdanbakhsh et al. 2002

Old friends trigger regulation through innate dendritic cell receptors

DISCLAIMER THIS SERIES OF SLIDES IS FOR PERSONAL USE ONLY. ANY OTHER APPLICATION MIGHT INFRINGE ON COPYRIGHTS or other rights. DO NOT COPY UNLESS PERMITTED. Prof.eric.claassen@gmail.com tel: +31 6 20443098 MEDIFOCUS LELYSTAD B.V.